Top Analysts Pick 3 Stocks to Buy Now: WIX, DDOG, and CTNM

Three stocks with significant upside potential, according to top analysts, are Wix.com Ltd. (WIX), Datadog (DDOG), and Continuum Therapeutics (CTNM). WIX has a 57.28% upside potential with 15 out of 17 top analysts recommending a buy, while DDOG has a 25.19% upside potential with 25 out of 29 top analysts recommending a buy. CTNM has a 171.6% upside potential with all three top analysts recommending a buy.

Three stocks with notable upside potential, according to top analysts, are Wix.com Ltd. (WIX), Datadog (DDOG), and Continuum Therapeutics (CTNM). These companies have been highlighted for their strong analyst support and growth prospects.

Wix.com Ltd. (WIX)

Wix.com, a leading cloud-based web development platform, has drawn significant attention from analysts. JMP Securities recently raised its price target for WIX from $160 to $200, indicating a potential upside of 54.58% from the current stock price [1]. This positive outlook is supported by a consensus rating of "Buy" and an average target price of $215.63, with 15 out of 17 top analysts recommending a buy rating.

The company's recent financial performance has been robust, with earnings per share (EPS) of $2.28 for the quarter, exceeding the consensus estimate of $1.79. Additionally, Wix.com announced a share repurchase plan to repurchase up to $200 million in shares, reflecting confidence in the company's valuation [1].

Datadog (DDOG)

Datadog, a cloud-based monitoring and analytics platform, has also received strong analyst support. The company has a 25.19% upside potential with 25 out of 29 top analysts recommending a buy rating. Analysts have cited Datadog's growing customer base and strong revenue growth as key drivers for the positive outlook.

Continuum Therapeutics (CTNM)

Continuum Therapeutics, a biotechnology company, has been identified as having the highest upside potential among the three stocks. All three top analysts recommend a buy rating, with a potential upside of 171.6%. The company's innovative approach to cancer therapy and strong clinical trial results have garnered analyst interest.

Conclusion

Wix.com, Datadog, and Continuum Therapeutics have been recognized for their significant upside potential by top analysts. Investors should closely monitor these companies for potential growth opportunities.

References

[1] https://www.marketbeat.com/instant-alerts/wixcom-nasdaqwix-stock-price-expected-to-rise-jmp-securities-analyst-says-2025-08-18/
[2] https://www.ainvest.com/news/wix-upgraded-buy-cfra-analyst-sets-price-target-159-2508/